Canada's supreme court has ruled against Harvard University in its long fight to win a Canadian patent for a genetically engineered mouse. The "oncomouse" has been patented in much of Europe, the US, Japan and New Zealand. Canada's biotech industry said the ruling would stifle investment. However, the country's medical research council said the potential savings on licence fees would allow researchers to better compete with larger operations.
请先注册再继续
为何要注册？
- 注册是免费的，而且十分便捷
- 注册成功后，您每月可免费阅读3篇文章
- 订阅我们的邮件
已经注册或者是已订阅？
Please or to read this article.